ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia.

D. Aufhauser Jr,1 D. Murken,1 Z. Wang,1 A. Samanta,2 G. Ge,1 T. Bhatti,3 P. Cole,4 J. Kalin,4 W. Hancock,2,3 M. Levine.1,5

1Surgery, University of Pennsylvania, Philadelphia, PA
2Pathology, University of Pennsylvania, Philadelphia, PA
3Pathology, Children's Hospital of Philadelphia, Philadelphia, PA
4Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD
5Surgery, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2017 American Transplant Congress

Abstract number: B129

Keywords: Graft function, Renal injury, Renal ischemia, Warm ischemia

Session Information

Session Name: Poster Session B: Ischemic Injury and Organ Preservation Session II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Introduction: Class I histone/protein deacetylases (HDACs) 1 and 2 bear >85% protein sequence homology and conventionally are thought to have similar function via occupancy in nuclear co-repressor complexes. Class I HDAC inhibition has been shown to mitigate renal warm ischemia-reperfusion injury (IRI) in mice.

Methods: Wild type C57BL/6 (WT) and whole animal-inducible HDAC1- or 2- gene deleted mice (HDAC1-/- or HDAC2-/-) were subjected to standardized warm renal IRI consisting of unilateral clamping of the renal pedicle and contralateral nephrectomy. Primary renal tubular epithelial cell (RTEC) cultures were derived from each genetic strain for protein analysis.

Results: HDAC1-/- mice have impaired IRI tolerance compared to B6 controls (p<0.01, Fig 1a) whereas HDAC2-/- mice demonstrate profound protection from renal IRI (p<0.01, Fig 1b). Protein analysis from RTEC nuclear extracts shows that deletion of either HDAC1 or 2 is associated with compensatory enhanced protein expression of the other. Pulldown experiments demonstrate that HDAC2 deletion leads to enhanced HDAC1 association with the CoREST nuclear co-repressor complexes and increased protein expression of co-repressor components. In vivo inhibition of the CoREST complex in both WT and HDAC2-/- mice increased vulnerability to renal IRI injury and returned HDAC2-/- mice to a WT renal IRI phenotype (Fig 1c).Conclusion: HDAC1 and 2 have reciprocal effects on murine renal IRI tolerance, with HDAC1 deletion increasing vulnerability and HDAC2 deletion providing substantial protection from warm and cold ischemia. HDAC2 deletion leads to alteration in expression and likely stability of nuclear co-repressor complexes, and its effect can be reversed with inhibition of the CoREST complex.

CITATION INFORMATION: Aufhauser Jr D, Murken D, Wang Z, Samanta A, Ge G, Bhatti T, Cole P, Kalin J, Hancock W, Levine M. Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Jr DAufhauser, Murken D, Wang Z, Samanta A, Ge G, Bhatti T, Cole P, Kalin J, Hancock W, Levine M. Nuclear Co-Repressor Complex Inhibition Reverses Benefit of HDAC2 Deletion in Renal Ischemia. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/nuclear-co-repressor-complex-inhibition-reverses-benefit-of-hdac2-deletion-in-renal-ischemia/. Accessed May 13, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences